Joint Annual Research Report 2005 - The Royal Marsden

REVIEW OF 2005
REVIEW OF 2005
from the Chairmen and Chief Executives
Lord Ryder
Chairman
The Institute of
Cancer Research
Peter Rigby
Chief Executive
The Institute of
Cancer Research
Tessa Green
Chairman
The Royal
Marsden NHS
Foundation Trust
Cally Palmer
Chief Executive
The Royal
Marsden NHS
Foundation Trust
We are delighted to present our
Annual Research Report for 2005,
which records another year of
important achievements and
significant progress in cancer research.
It contains in-depth reviews of recent,
exciting developments in several areas
of our work, and provides addresses
for various web resources which give
comprehensive information on all
aspects of our activities.
The Institute of Cancer Research and
The Royal Marsden NHS Foundation
Trust form the largest Comprehensive
Cancer Centre in Europe, and one
of the largest in the world, which
has an outstanding national and
international reputation. Our
mission, "to relieve human suffering
by pursuing excellence in the fight
against cancer", is carried out within
a framework of activities in research
and development, education and
training, and the treatment and care
of people affected by cancer.
Our clinicians and scientists
collaborate through the Joint Research
Committee on research strategy and
priorities. Recent developments
supported by the hospital and The
Institute include investment in
academic surgery with the newly
established Paul Hamlyn Chair of
Surgery, held jointly between the Royal
Marsden, The Institute and Imperial
College by Professor Sir Ara Darzi, the
highly successful performance of the
Oak Foundation Drug Development
Unit and investment in a PET/CT
scanner to support imaging research
and the Drug Development
Programme. We work, like other
world-class centres of excellence, in
a truly international context and in
partnership with many research
institutions and funding agencies.
Oak Foundation Drug Development Unit
4